| abstract |
The present invention relates to hydroalcoholic transdermal testosterone gel formulations, which have the problems associated with other testosterone delivery mechanisms by having a desirable pharmacokinetic profile of the hormone, with little or no skin irritation, among others. Overcoming. In addition, this gel is used in conjunction with pharmaceuticals to enhance the efficacy of pharmaceuticals intended for the treatment of erectile dysfunction, such as VIAGRA®. |